Iron deficiency anaemia
Conditions
Interventions
Trade Name: Profer 40 mg Granulado
Product Name: Profer 40 mg Granulado
Pharmaceutical Form: Granules for oral solution
INN or Proposed INN: ferrimannitol ovalbumin
Concentration unit: mg milligram(s)
Sponsors
TEDEC MEIJI FARMA, S.A.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients > 18 years old Diagnosis of iron deficiency anaemia Informed consent Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Anaemia not related with iron deficiency Pregnancy and lactation Diseases with iron overload Patients who have received iron treatment within the previous 3 months prior to the inclusion in the study. Digestive pathology that may cause intolerance or malabsortion Hepatic insufficiency Chronic pancreatitis Renal insufficiency AIDS or seropositive patients, infection, neoplasia or continuos haemorrhage
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: To assess the efficacy and tolerability of both study drugs in the treatment of iron deficiency anaemia;Secondary Objective: ;Primary end point(s): Recovery of the haematological parameters with or without clinical improvement | — |
Countries
Spain
Outcome results
None listed